Quarry LP Xeris Biopharma Holdings, Inc. Transaction History
Quarry LP
- $470 Billion
- Q2 2025
A detailed history of Quarry LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Quarry LP holds 162,500 shares of XERS stock, worth $1.5 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
162,500
Previous 70,751
129.68%
Holding current value
$1.5 Million
Previous $388 Million
95.37%
% of portfolio
0.16%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
208Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$95.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$90.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$35.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$33.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.26B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...